BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25808075)

  • 21. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel insights on lymphoma and lymphomagenesis in primary Sjögren's Syndrome.
    Alunno A; Leone MC; Bartoloni E; Gerli R; Carubbi F
    Panminerva Med; 2021 Dec; 63(4):491-498. PubMed ID: 33274907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of light chain restriction in labial gland biopsies of Sjögren's syndrome detected by in situ hybridization.
    Jordan RC; Pringle JH; Speight PM
    J Pathol; 1995 Sep; 177(1):35-40. PubMed ID: 7472777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
    Nagai K
    Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
    Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
    Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
    Risselada AP; Kruize AA; Bijlsma JW
    Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary monoclonal free light chains in primary Sjögren's syndrome: an aid to the diagnosis of malignant lymphoma.
    Walters MT; Stevenson FK; Herbert A; Cawley MI; Smith JL
    Ann Rheum Dis; 1986 Mar; 45(3):210-9. PubMed ID: 3082300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pseudolymphoma in Sjögren's syndrome: cross spectrum of autoimmune disease and malignant lymphoma].
    Nakao Y; Kishihara M; Yoshimi H; Chiba T; Yamada T; Baba Y; Matsukura S; Fujita T
    Nihon Rinsho; 1980 Feb; 38(2):392-401. PubMed ID: 7392230
    [No Abstract]   [Full Text] [Related]  

  • 29. CD5 positivity on peripheral blood B lymphocytes in patients with primary Sjögren's syndrome.
    Zeher M; Surányi P; Szegedi G
    Allergol Immunopathol (Madr); 1990; 18(2):75-8. PubMed ID: 1695475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac involvement in primary Sjӧgren's syndrome.
    Qin L; Zhang Y; Yang X; Luo Q; Wang H
    Rheumatol Int; 2022 Feb; 42(2):179-189. PubMed ID: 34387735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary lymphomas of the major salivary glands.
    Batsakis JG
    Ann Otol Rhinol Laryngol; 1986; 95(1 Pt 1):107-8. PubMed ID: 3946996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
    Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
    Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The risk of lymphoma in Sjögren's syndrome].
    Thieblemont C; Galicier L
    Rev Prat; 2012 Feb; 62(2):232-3. PubMed ID: 22408872
    [No Abstract]   [Full Text] [Related]  

  • 34. [Sjögren's syndrome with pseudolymphoma].
    Zittoun R; Lebon P; Diebold J
    Ann Med Interne (Paris); 1974 Nov; 125(11):831-6. PubMed ID: 4218715
    [No Abstract]   [Full Text] [Related]  

  • 35. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
    Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM
    Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
    Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
    Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-cell lymphoproliferation in primary Sjögren's syndrome.
    Tzioufas AG
    Clin Exp Rheumatol; 1996; 14 Suppl 14():S65-70. PubMed ID: 8722203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Hodgkin's lymphoma and Sjögren's syndrome. An immunopathological study of 113 patients.
    Janin A; Morel P; Quiquandon I; Farre I; Hatron PY; Bauters F; Gosselin B
    Clin Exp Rheumatol; 1992; 10(6):565-70. PubMed ID: 1483307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study.
    Baldini C; Santini E; Rossi C; Donati V; Solini A
    J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary tumours in Sjögren's syndrome.
    Kovács L; Szodoray P; Kiss E
    Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.